scholarly journals Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin

2001 ◽  
Vol 3 (3) ◽  
pp. 181-188 ◽  
Author(s):  
Nathalie Mielcarek ◽  
Elisabeth Hultgren Hornquist ◽  
Bengt R. Johansson ◽  
Camille Locht ◽  
Soman N. Abraham ◽  
...  
Keyword(s):  
Mast Cells ◽  
Pertussis Toxin ◽  
Bordetella Pertussis ◽  
Cytokine Secretion

scholarly journals Importance of Holotoxin Assembly in Ptl-Mediated Secretion of Pertussis Toxin from Bordetella pertussis

2000 ◽  
Vol 68 (7) ◽  
pp. 4049-4054 ◽  
Author(s):  
Karen M. Farizo ◽  
Theresa Huang ◽  
Drusilla L. Burns
Keyword(s):  
Pertussis Toxin ◽  
Bordetella Pertussis ◽  
Structural Components ◽  
Type Iv ◽  
System A

ABSTRACT We examined the structural components of pertussis toxin that are required for efficient export from Bordetella pertussis via the Ptl system, a member of the type IV family of macromolecular transporters. First, we constructed a strain of B. pertussis that contains a functional Ptl system but does not produce pertussis toxin. Plasmids which express either the S1 subunit or the B oligomer were then introduced into this strain. We found that the B oligomer of the toxin is not secreted in the absence of the S1 subunit. Conversely, the S1 subunit is also not secreted by a Ptl-mediated mechanism in the absence of the B oligomer. Thus, an assembled holotoxin is required for Ptl-mediated export of pertussis toxin from B. pertussis.

scholarly journals Natural polyamines stimulate G-proteins

1992 ◽  
Vol 282 (2) ◽  
pp. 545-550 ◽  
Author(s):  
J L Bueb ◽  
A Da Silva ◽  
M Mousli ◽  
Y Landry
Keyword(s):  
Mast Cells ◽  
Pertussis Toxin ◽  
Inositol Phosphates ◽  
Second Messengers ◽  
G Protein Coupled Receptors ◽  
Extracellular Signals ◽  
Physiological Relevance ◽  
G Protein Coupled ◽  
Stimulation Of ◽  
Rat Mast Cells

The natural polyamines spermine and spermidine, the biosynthetic precursor putrescine and their analogues cadaverine and tyramine stimulate the GTPase activity of purified GTP-binding proteins (Go/Gi) from calf brain reconstituted into phospholipid vesicles. The order of potency was spermine greater than spermidine greater than putrescine = cadaverine greater than tyramine. The physiological relevance of this observation was assessed, showing the same order of potency of polyamines in the stimulation of peritoneal and tracheal rat mast cells. The activation of rat mast cells by polyamines was inhibited by benzalkonium chloride or by a 2 h pretreatment of the cells with pertussis toxin. The increase in inositol phosphates evoked by polyamines was also inhibited by pertussis toxin. Therefore we propose that intracellular polyamines might control the basal level of second messengers and modulate extracellular signals transduced through G-protein-coupled receptors.

Bordetella Pertussis Antibody Levels in DPT/Pentavalent Immunized Preschool Nigerian Children: A Cross-Sectional Study

2019 ◽  
Vol 15 (01) ◽  
pp. 011-015
Author(s):  
Glory Ekpo Bassey ◽  
Emmanuel Eyo Ekanem ◽  
Henry Chima Okpara ◽  
Komomo Ibor Eyong
Keyword(s):  
Pertussis Toxin ◽  
Bordetella Pertussis ◽  
Age Groups ◽  
Booster Vaccination ◽  
Rapid Decline ◽  
Age Group ◽  
Igg Antibodies ◽  
Cross Sectional ◽  
Nigerian Children ◽  
Antibody Levels

AbstractPertussis is a vaccine-preventable disease and antibodies formed are known to decline with time. The aim of this study was to measure Bordetella pertussis/toxin immunoglobulin G (IgG) antibodies in different age groups of Nigerian children and determine the age at which booster dose may be required. A total of 422 children, aged 6 to 60 months, were tested for the presence of B. pertussis/toxin IgG antibodies by ELISA (enzyme-linked immune sorbent assay). The highest positivity rate was in the 6 to 11 months of age group, while the highest negativity rate was in the age group of 24 to 35 months. We conclude that B. Pertussis/toxin IgG antibodies response is weak in Nigerian children after three doses of DPT (diphtheria, pertussis, and tetanus)/pentavalent vaccination, and there is a rapid decline of antibody levels between 12 and 35 months. We recommend that booster vaccination should be given at 12 to 15 months of age.

Sign in / Sign up

Export Citation Format

Share Document